Treatment with a polymyxin B filter to capture endotoxin in sepsis patients: is there a signal for therapeutic efficacy?
Authors:
Open Access
- 3 December 2018
- journal article
- editorial
- Published by Springer Nature in Intensive Care Medicine
- Vol. 45 (2) , 282-283
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trialIntensive Care Medicine, 2018
- Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin LevelJAMA, 2018
- Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trialIntensive Care Medicine, 2015
- Blood Purification and Mortality in SepsisCritical Care Medicine, 2013
- Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisJAMA, 2013
- Polymyxin B Hemoperfusion and Mortality in Abdominal Septic ShockJAMA, 2009
- Early Use of Polymyxin B Hemoperfusion in Abdominal Septic ShockJAMA, 2009
- Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic ShockThe Journal of Infectious Diseases, 1999